Lv1
90 积分 2022-02-15 加入
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein
12天前
已关闭
Therapeutic targeting of RAS-mediated resistance in oncogene-driven lung cancer
30天前
已完结
Targeted KRASG12V Degradation In Vivo Elicits Lung Adenocarcinoma Regression with Subsequent Relapse from Dysregulated Proteolysis
1个月前
已完结
Response and Resistance to RAS Inhibition in Cancer
3个月前
已完结
Screening approaches for kinases
3个月前
已关闭
HER2 heterogeneous breast cancer models reveal novel therapeutic targets and subclonal dynamics during evolution to resistance to HER2-targeted therapies
4个月前
已完结
Screening approaches for kinases
4个月前
已关闭
Direct Inhibition of RAS Reveals the Features of Oncogenic Signaling Driven by RAS G12 and Q61 Mutations
5个月前
已完结
P3.12.26 Adding Gefitinib to Target Acquired C797S Mutation After Progression on First-Line Osimertinib in EGFR-Mutant Advanced NSCLC
5个月前
已关闭
Challenges and opportunities of emerging mechanisms of resistance to KRASG12C inhibitors
6个月前
已完结
皖公网安备34019202002308
